DETAILED NOTES ON LYCORINE

CRC has an immunosuppressive TME which stops the event of a good response to ICB therapies. There exists As a result an urgent have to identify the means reprogram this suppressive TME as a way to boost immunotherapy efficacy. In The existing examine, we used CRISPR KO screens to find genes that sensitize CRC to antitumor immunity in host mice that